<- Go Home
Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and ultrasound imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Market Cap
NOK 4.2B
Volume
16.9K
Cash and Equivalents
NOK 209.8M
EBITDA
NOK 201.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
NOK 581.1M
Profit Margin
80.71%
52 Week High
NOK 292.00
52 Week Low
NOK 186.50
Dividend
3.51%
Price / Book Value
8.23
Price / Earnings
26.70
Price / Tangible Book Value
10.09
Enterprise Value
NOK 4.0B
Enterprise Value / EBITDA
19.03
Operating Income
NOK 194.1M
Return on Equity
32.08%
Return on Assets
18.68
Cash and Short Term Investments
NOK 209.8M
Debt
NOK 34.6M
Equity
NOK 506.7M
Revenue
NOK 719.9M
Unlevered FCF
NOK 118.2M
Sector
Health Care Equipment and Supplies
Category
N/A